11 results
10-K
2023 FY
MIRA
Mira Pharmaceuticals Inc
1 Apr 24
Annual report
7:00am
reputation may suffer. The reputational risk is heightened with respect to those of our product candidates that are being developed for pediatric
424B4
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus supplement with pricing info
1:01pm
collaboration partners may suffer;
we could be sued and held liable for harm caused to patients; or
our reputation may suffer. The reputational risk
424B1
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus with pricing info
12:59pm
;
we could be sued and held liable for harm caused to patients; or
our reputation may suffer. The reputational risk is heightened with respect to those
S-1
mlorhezxyy4x8tduablt
29 Jun 23
IPO registration
4:39pm
DRS/A
uka384m
8 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
5d7dexwbqwfhwo oec
2 May 23
Draft registration statement (amended)
12:00am
DRS
0onenpc
29 Jun 22
Draft registration statement
12:00am
- Prev
- 1
- Next